27 Aug, 2026

Shutting down a zombie biotech

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. How does a biotech company […]

1 min read

Kennedy cancels $500 million in mRNA vaccine contracts

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on Signal at hbranswell.01. Health secretary Robert F. Kennedy Jr. on Tuesday announced that the government’s emergency preparedness agency will no longer fund work on messenger RNA vaccines, delivering […]

2 mins read

Rising anti-vaccine sentiment in U.S. will exact heavy toll overseas

Billionaire philanthropist Bill Gates expressed concern Monday about growing vaccine skepticism in the United States, suggesting that the exporting of claims by the anti-vaccine movement will likely extract a bigger death toll internationally than domestically and could also put the possibility of ridding the world of measles permanently out of reach. “Vaccine skepticism in the […]

5 mins read

Who is involuntary commitment for?

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them. You can submit a […]

11 mins read